Clinical Trial Update: A Phase III Study of Abatacept in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate [Phase 3]

View source ↗

Summary

A Phase III trial evaluated abatacept in rheumatoid arthritis patients with an inadequate response to methotrexate; the study completed and results were posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ORENCIA (ABATACEPT)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2010-01-26